Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Technology Policy
- 
            
            
        Iain M. Cockburn
        
 and Scott Stern 
This paper considers the drivers of the structure and evolution of the life sciences innovation system, a remarkable success story for public support of science. The growth and performance of this system reflect the interaction between abundant scientific and technological opportunity, a reasonably effective and adaptive institutional and property rights framework, and a reservoir of unmet demand for therapies and technologies that significantly enhance human health care. Examining the evolution and dynamism of the life sciences innovation system, we emphasize three central foundations: a long-term and relatively stable commitment of financial and human resources by both the public sector and for-profit organizations, market and non-market institutions that encourage competition on the basis of innovation across multiple dimensions, and the promise of significant financial rewards for private sector innovators leveraging publicly funded scientific discoveries.
©2011 Walter de Gruyter GmbH & Co. KG, Berlin/Boston
Articles in the same Issue
- Article
 - Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Technology Policy
 - Pharmaceutical Price Discrimination and Social Welfare
 - Immigrant Entrepreneurs in U.S. Financial History, 1775-1914
 - Discussion and Commentary
 - Comment on "Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Technology Policy" (by Iain M. Cockburn and Scott Stern)
 - Comment on "Pharmaceutical Price Discrimination and Social Welfare" (by Frank R. Lichtenberg)
 - Comment on "Immigrant Entrepreneurs in U.S. Financial History, 1775-1914" (by Thomas K. McCraw)
 
Articles in the same Issue
- Article
 - Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Technology Policy
 - Pharmaceutical Price Discrimination and Social Welfare
 - Immigrant Entrepreneurs in U.S. Financial History, 1775-1914
 - Discussion and Commentary
 - Comment on "Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Technology Policy" (by Iain M. Cockburn and Scott Stern)
 - Comment on "Pharmaceutical Price Discrimination and Social Welfare" (by Frank R. Lichtenberg)
 - Comment on "Immigrant Entrepreneurs in U.S. Financial History, 1775-1914" (by Thomas K. McCraw)